Medtronic has been hiking its dividend for nearly 50 consecutive years. It's spinning off its diabetes division to focus on faster-growing businesses. Its strategy makes sense -- and its valuation is ...

Feb 24 (Reuters) - Medtronic's (MDT.N), opens new tab MiniMed Group said on Tuesday it was targeting up to $7.86 billion valuation in its U.S. initial public offering, marking a step forward in the ...

Medtronic is one of the world's largest medical device companies. Its dividend streak speaks volumes about the strength of its business. Medtronic has increased its dividends for 48 consecutive years.

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Medtronic’s modeled fair value price target has been ...

The terms "dividend" and "healthcare stock" usually aren't mentioned in the same sentence. They're almost unavoidable together when talking about Medtronic (NYSE: MDT), however. The company is not ...

March 6 (Reuters) - Shares of MiniMed, the diabetes business of medical device maker Medtronic, opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion. The ...

MiniMed Group (MMED) lost ~5% as Medtronic’s (MDT) diabetes business began trading as a public company on Thursday following its separation from the parent via an IPO that raised $560M for the insulin ...

MiniMed Group (MMED), a diabetes care company and a subsidiary of Medtronic (MDT), priced its initial public offering of 28M shares at $20 per share. The offering is expected to raise $560M. The ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following ...